Thursday, May 03, 2001
What's the Buzz?
Duramed gets OK for generic drug
Duramed Pharmaceuticals Inc. has received U.S. Food and Drug Administration approval to produce a generic version of the oral contraceptive Alesse, which had sales of $130 million in 2000.
Duramed's new Aviane oral contraceptive will join the Apri oral contraceptive and Cenestin conjugated estrogen drug in the Pleasant Ridge drug maker's stable of hormone products.
Duramed plans to begin shipping Aviane — the only generic version of Alesse — in early May.
“Based on the track record of our other oral contraceptive, Apri, we look forward to the revenue contribution Aviane will make,” Duramed chief executive officer E. Thomas Arington said.
— Randy Tucker
Have a tip about a Tristate company that should be included in our Buzz? Call 768-8147 or e-mail business@enquirer.com.
Comair kills weekend deal
Delta gets new day-to-day boss
Bush waits to reform Social Security
Building a Zaring legacy
Land for garage to cost $2M
Liquid Oxydol aimed at Gen X
Big 1st-quarter turnaround at Duramed
Ex-governor goes from best of times to worst
Business Digest
Industry notes: Marketing and advertising
Morning Memo
Tristate Business Summary
What's the Buzz?
